Expensive medicines: ensuring objective appraisal and equitable access
Hill, Suzanne R; Bero, Lisa; McColl, Geoff; Roughead, Elizabeth.
Bull. W.H.O. (Print)
; 93(1): 4-4, 2015-1-01.
Artículo en Inglés | WHOLIS | ID: who-271637
Documentos relacionados
[Herbal medicines: when to use or not to use?].
[Experiences when handling sleep medicines: Group discussions with nursing students about benzodiazepines and Z-drugs].
[Biosimilar medicines: OsMed reports on monitoring consumption and spending in Italy.]
[European registration of medicines: pros and cons for prescriber and patient].
The AIDS Epidemic and the Mozambican Society of Medicines: an analysis of Brazilian cooperation.
[Safe administration of medicines: learning from our mistakes].
[Injection medicines: historical notes on their use and development, with special reference to Icelandic conditions].
[Collaboration between traditional and modern medicines: prospectives of structuring a combined care system for traumatology cases].
[Class substitution as an instrument of efficiency in the supply of medicines: possibilities and limitations].
[Quantifying the additional clinical benefit of new medicines: little - considerable - significant - 6 remarks from a biometrician's point of view].